17 Jun 2021
The Role of Collaboration in Optimizing the Development of HIF Inhibitors for the Treatment of Advan
Speaker: Margaret Offermann, M.D., Ph.D. (CEO, OncoSpherix)
Crystal Pharmatech is pleased to announce our new webinar series: "Molecules-to-Medicine: Accelerating Drug Development through Collaboration". Purpose: To communicate the extraordinary ingenuity taking place in 21st century drug discovery and development and that a good idea is just the first step in creating a medicine. In a nutshell, why CMC matters and how collaboration can accelerate development. Presenters: Innovative pharmaceutical scientists and entrepreneurs showcasing novel therapeutic technologies with a focus on how a molecule becomes a medicine.